EpiPen Maker Mylan Tied Pay to Aggressive Profit Targets

The drugmaker at the center of a firestorm over hefty price increases on the lifesaving EpiPen put a special incentive plan in place more than two years ago that rewards executives only if they hit aggressive profit targets.